ReviewPain and therapy2021

Real-World Evidence for Control of Chronic Migraine Patients Receiving CGRP Monoclonal Antibody Therapy Added to OnabotulinumtoxinA: A Retrospective Chart Review.

Andrew M Blumenfeld et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.